Search - tctmd.com

Displaying 1 - 20 of 206

Sort: Relevancy | Date

Presentation Miami Valves 2023

What’s New In Renal Denervation?

Presenter: Sergio Perez

February 04, 2023

Presentation Miami Valves 2023

Cardiorenal Syndrome and Renal Protection: Fact Vs Fiction

Presenter: Mrudula R. Munagala

February 02, 2023

Presentation AHA 2022

Renal Denervation in the Presence of Anti-Hypertensive Medications: Six-Month Results from the Randomized, Blinded, Sham-Controlled SPYRAL HTN – ON MED Trial

Presenter: David E. Kandzari

November 07, 2022

Presentation EuroPCR 2022

Blood pressure and MACE reductions after renal denervation: 3-year GSR results

Presenter: Felix Mahfoud

May 20, 2022

Presentation ARCH 2022

Current Status and Future of Renal Denervation for Hypertension

Presenter: Tim A. Fischell

April 23, 2022

Presentation ACC 2019

Chemical Renal Denervation with Alcohol: The Post-Market Study Data and The Target BP Program

Presenter: Horst Sievert

March 18, 2019

Presentation Cardiovascular Interventions 2018

Imaging and physiology-guided PCI without contrast administration in advanced renal failure

Presenter: Ziad A. Ali

October 26, 2018

Presentation CDM 2018

The Hope and Promise of Renal Denervation

Presenter: Michael A.Weber

October 12, 2018

Presentation TCT Abstracts Posters 2018

Impact of HDL to major adverse limb event in end-stage renal disease on hemodialysis due to diabetic nephropathy. from PREDICT study

Presenter: Tamon Kato

September 25, 2018

Presentation ISET 2017

Dislodged Stent During Placement

Presenter: J. Fritz Angle

February 04, 2017

Presentation SOLACI 2016

Denervación Renal - Donde estamos hoy?

Presenter: Humberto Casal Pati?o

June 10, 2016

Presentation Fellows 2016

Renal Artery Interventions: Current State of the Field

Presenter: Sahil A. Parikh, Duane S. Pinto

April 17, 2016

Presentation ISET 2016

Renal Artery Stenting in Association with EVAR: Technical Considerations

Presenter: Marcelo Guimaraes

February 09, 2016

Presentation ISET 2016

Drug-Coated Balloons for Renal FMD

Presenter: Fabrizio Fanelli

February 09, 2016

Presentation

Quantifying the 3 Biases That Lead to Unintentional Overestimation of the Effect of Renal Denervation

Presenter: James P. Howard

January 11, 2016

Presentation

PROTECT-TAVI: AKI With the RenalGuard System in Patients Undergoing TAVR

Presenter: Marco Barbanti

September 21, 2015

Presentation CCVVC 2015

New Concepts in Endovascular Treatment: Present And Future Status Of Renal Denervation After The Negative SIMPLICITY Trial

Presenter: Mark Wholey

June 17, 2015

Presentation

Case Presentation: Severe Renal Disease and TAVR

Presenter: Howard C. Herrmann, Alec S. Vahanian, Philippe Genereux

June 04, 2015

Presentation Fellows 2015

Renal Artery Interventions: Current State of the Field

Presenter: William A. Gray, Duane S. Pinto

May 17, 2015

Presentation ARCH 2015

Renal Denervaton ~ Early Trials

Presenter: Rothstein Marcos

April 11, 2015

Advertisement

What’s New In Renal Denervation?

Cardiorenal Syndrome and Renal Protection: Fact Vs Fiction

Renal Denervation in the Presence of Anti-Hypertensive Medications: Six-Month Results from the Randomized, Blinded, Sham-Controlled SPYRAL HTN – ON MED Trial

Blood pressure and MACE reductions after renal denervation: 3-year GSR results

Current Status and Future of Renal Denervation for Hypertension

Chemical Renal Denervation with Alcohol: The Post-Market Study Data and The Target BP Program

Imaging and physiology-guided PCI without contrast administration in advanced renal failure

The Hope and Promise of Renal Denervation

Impact of HDL to major adverse limb event in end-stage renal disease on hemodialysis due to diabetic nephropathy. from PREDICT study

Dislodged Stent During Placement

Denervación Renal - Donde estamos hoy?

Renal Artery Interventions: Current State of the Field

Renal Artery Stenting in Association with EVAR: Technical Considerations

Drug-Coated Balloons for Renal FMD

Quantifying the 3 Biases That Lead to Unintentional Overestimation of the Effect of Renal Denervation

PROTECT-TAVI: AKI With the RenalGuard System in Patients Undergoing TAVR

New Concepts in Endovascular Treatment: Present And Future Status Of Renal Denervation After The Negative SIMPLICITY Trial

Case Presentation: Severe Renal Disease and TAVR

Renal Artery Interventions: Current State of the Field

Renal Denervaton ~ Early Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content